Studies have however shown that elevated levels of herpes virus entry protein A (Hve-A) are produced in CLL patients [4], which contribute to viral entry via direct binding to HSV glycoprotein D molecule [8]. This evidence concerns the gene TNFRSF14 and B-cell chronic lymphocytic leukemia.